damoctocog alfa pegol sold brand name jivi recombinant dnaderived factor viii concentrate medication used treat hemophilia common side effects include headache cough nausea damoctocog alfa pegol antihemophilic factor recombinant pegylatedaucl approved medical use united states august european union november united states damoctocog alfa pegol indicated use previously treated adults adolescents twelve years age older hemophilia congenital factor viii deficiency ondemand treatment control bleeding episodes perioperative management bleeding routine prophylaxis reduce frequency bleeding european union damoctocog alfa pegol indicated treatment prophylaxis bleeding previously treated people twelve years age older haemophilia congenital factor viii httpsenwikipediaorgwikidamoctocogalfapegol